BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 27422418)

  • 1. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
    Ray JG; Ranganathan K; Chattopadhyay A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
    Chattopadhyay A; Ray JG
    J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral submucous fibrosis: review on mechanisms of malignant transformation.
    Ekanayaka RP; Tilakaratne WM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):192-9. PubMed ID: 27289264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
    Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
    Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
    Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
    J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral submucous fibrosis. The South African experience.
    VanWyk CW
    Indian J Dent Res; 1997; 8(2):39-45. PubMed ID: 9495135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases.
    Jayasinghe LA; Peiris PM; Tilakaratne WM; Attygalla AM; Jayasinghe RD; Sitheeque MA; Siriwardena BS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):210-5. PubMed ID: 27422419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
    Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
    Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a combined biomarker for malignant transformation in oral submucous fibrosis.
    Bazarsad S; Zhang X; Kim KY; Illeperuma R; Jayasinghe RD; Tilakaratne WM; Kim J
    J Oral Pathol Med; 2017 Jul; 46(6):431-438. PubMed ID: 27497264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China.
    Liu B; Shen M; Xiong J; Yuan Y; Wu X; Gao X; Xu J; Guo F; Jian X
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):337-45. PubMed ID: 26130067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
    Auluck A; Rosin MP; Zhang L; Sumanth KN
    J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral submucous fibrosis. A review.
    Cox SC; Walker DM
    Aust Dent J; 1996 Oct; 41(5):294-9. PubMed ID: 8961601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.
    Mohiuddin S; Fatima N; Hosein S; Fatima N
    J Pak Med Assoc; 2016 Nov; 66(11):1362-1366. PubMed ID: 27812049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis.
    Yaming P; Urs AB; Saxena A; Zuberi M
    Asian Pac J Cancer Prev; 2016; 17(7):3335-40. PubMed ID: 27509973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
    Phulari RGS; Dave EJ
    Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis.
    Cirillo N; Duong PH; Er WT; Do CTN; De Silva MEH; Dong Y; Cheong SC; Sari EF; McCullough MJ; Zhang P; Prime SS
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral submucous fibrosis: An enigmatic morpho-insight.
    Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
    J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China.
    Tang JG; Jian XF; Gao ML; Ling TY; Zhang KH
    Community Dent Oral Epidemiol; 1997 Apr; 25(2):177-80. PubMed ID: 9181294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.